Orphan designation: Milatuzumab, Treatment of chronic lymphocytic leukaemia

Case Medical Research ◽

10.31525/cmr-29b43a5 ◽

2020 ◽

Author(s):

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Orphan Designation

Download Full-text

Orphan designation: Forodesine, Treatment of chronic lymphocytic leukaemia

Case Medical Research ◽

10.31525/cmr-133691a ◽

2019 ◽

Author(s):

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Orphan Designation

Download Full-text

Orphan designation: (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one (duvelisib), Treatment of chronic lymphocytic leukaemia / small lymphocytic lymphoma

Case Medical Research ◽

10.31525/cmr-22b3214 ◽

2019 ◽

Author(s):

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Small Lymphocytic Lymphoma ◽

Orphan Designation

Download Full-text

Orphan designation: Recombinant chimeric monoclonal antibody against CD20, Treatment of chronic lymphocytic leukaemia

Case Medical Research ◽

10.31525/cmr-17cd5cc ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Orphan Designation ◽

Chimeric Monoclonal Antibody

Download Full-text

Orphan designation: Humanised single-chain monoclonal antibody against CD37 (otlertuzumab), Treatment chronic lymphocytic leukaemia

Case Medical Research ◽

10.31525/cmr-b3220b ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Single Chain ◽

Orphan Designation

Download Full-text

Orphan designation: Dinaciclib, Treatment of chronic lymphocytic leukaemia

Case Medical Research ◽

10.31525/cmr-399645 ◽

2018 ◽

Author(s):

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Orphan Designation

Download Full-text

Orphan designation: Veltuzumab, Treatment of chronic lymphocytic leukaemia

Case Medical Research ◽

10.31525/cmr-2b1b808 ◽

2020 ◽

Author(s):

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Orphan Designation

Download Full-text

Orphan designation: 4-(4-{[2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide (venetoclax), Treatment of chronic lymphocytic leukaemia

Case Medical Research ◽

10.31525/cmr-45771b ◽

2018 ◽

Author(s):

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Orphan Designation

Download Full-text

Orphan designation: 4-(4-{[2-(4-Chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide (venetoclax), Treatment of chronic lymphocytic leukaemia

Case Medical Research ◽

10.31525/cmr-587226 ◽

2018 ◽

Author(s):

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Orphan Designation

Download Full-text

Orphan designation: Humanised single-chain monoclonal antibody against CD37 (otlertuzumab), Treatment chronic lymphocytic leukaemia

Case Medical Research ◽

10.31525/cmr-b2f864 ◽

2019 ◽

Author(s):

Keyword(s):

Monoclonal Antibody ◽

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Single Chain ◽

Orphan Designation

Download Full-text

Orphan designation: ofatumumab, Treatment of chronic lymphocytic leukaemia

Case Medical Research ◽

10.31525/cmr-3996a6 ◽

2018 ◽

Author(s):

Keyword(s):

Chronic Lymphocytic Leukaemia ◽

Lymphocytic Leukaemia ◽

Orphan Designation

Download Full-text